LYRA THERAPEUTICS INC

CUSIP: 55234L105 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 1,765,585 Value ($000) $222 Avg Close — Range —
Q4 2024
Shares 1,787,422 Value ($000) $368 Avg Close — Range —
Q3 2024
Shares 1,779,263 Value ($000) $457 Avg Close — Range —
Q2 2024
Shares 1,730,915 Value ($000) $479 Avg Close — Range —
Q1 2024
Shares 1,481,481 Value ($000) $9,215 Avg Close — Range —
Q4 2023
Shares 1,071,460 Value ($000) $5,614 Avg Close — Range —
Q3 2023
Shares 864,332 Value ($000) $3,380 Avg Close — Range —
Q2 2023
Shares 790,936 Value ($000) $3,251 Avg Close — Range —
Q1 2023
Shares 790,936 Value ($000) $1,590 Avg Close — Range —
Q4 2022
Shares 790,936 Value ($000) $2,484 Avg Close — Range —
Q3 2022
Shares 790,620 Value ($000) $3,961 Avg Close — Range —
Q2 2022
Shares 675,669 Value ($000) $3,817 Avg Close — Range —
Q1 2022
Shares 218,753 Value ($000) $879 Avg Close — Range —
Q4 2021
Shares 218,753 Value ($000) $954 Avg Close — Range —
Q3 2021
Shares 220,029 Value ($000) $2,008 Avg Close — Range —
Q2 2021
Shares 220,029 Value ($000) $1,767 Avg Close — Range —
Q1 2021
Shares 211,886 Value ($000) $2,456 Avg Close — Range —
Q4 2020
Shares 173,723 Value ($000) $1,980 Avg Close — Range —
Q3 2020
Shares 151,625 Value ($000) $1,695 Avg Close — Range —
Q2 2020
Shares 34,659 Value ($000) $393 Avg Close — Range —